v3.26.1
Stockholders' Equity (Tables)
12 Months Ended
Apr. 30, 2026
Equity [Abstract]  
Summary of Movements of Company's Stock Options

The following outlines movements of the Company’s stock options:

 

 

 

Number of
options

 

 

Weighted Average
 Exercise Price
 ($CAD)

 

Balance at April 30, 2025

 

 

2,018,300

 

 

 

3.48

 

     Granted

 

 

381,788

 

 

 

5.66

 

     Forfeited

 

 

(117,574

)

 

 

3.22

 

     Exercised

 

 

(311,864

)

 

 

3.65

 

Balance at April 30, 2026

 

 

1,970,650

 

 

 

3.90

 

Schedule of Black Scholes Options Pricing Model

The fair value of these stock options was estimated at the date of grants, using the Black-Scholes option pricing model with the following weighted average assumptions:

 

 

For the year ended April 30,

 

 

2026

 

 

2025

 

 

2024

 

Risk-free interest rate

 

2.59

%

 

 

2.94

%

 

 

4.28

%

Expected life (years)

 

4.00

 

 

 

4.00

 

 

 

3.90

 

Expected volatility

 

65.90

%

 

 

69.19

%

 

 

71.46

%

Expected dividend yield

 

0.00

%

 

 

0.00

%

 

 

0.00

%

Grant date weighted average fair value

CAD$3.02

 

 

CAD$2.12

 

 

CAD$1.69

 

Schedule of Outstanding Unvested Stock Options

The following outlines movements of the Company’s outstanding unvested stock options:

 

 

 

Number of
options

 

 

Weighted Average
 Exercise Price
 ($CAD)

 

Balance at April 30, 2025

 

 

195,750

 

 

 

3.92

 

     Granted

 

 

381,788

 

 

 

5.66

 

     Forfeited

 

 

(5,188

)

 

 

5.39

 

     Vested

 

 

(384,082

)

 

 

4.71

 

Balance at April 30, 2026

 

 

188,268

 

 

 

5.66

 

Summary of Stock Options Outstanding and Exercisable

A summary of stock options outstanding and exercisable at April 30, 2026, are as follows:

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise Price
($CAD)

 

Number of Options
Outstanding

 

 

Weighted Average Exercise Price
($ CAD)

 

 

Weighted Average Remaining Contractual Life
(years)

 

 

Number of Options Exercisable

 

 

Weighted Average Exercise Price
($ CAD)

 

 

Weighted Average Remaining Contractual Life
(years)

 

2.00 to 2.99

 

 

383,300

 

 

 

2.92

 

 

 

2.31

 

 

 

383,300

 

 

 

2.92

 

 

 

2.31

 

3.00 to 3.99

 

 

1,130,088

 

 

 

3.57

 

 

 

1.61

 

 

 

1,113,294

 

 

 

3.57

 

 

 

1.57

 

4.00 to 4.99

 

 

73,000

 

 

 

4.13

 

 

 

0.88

 

 

 

73,000

 

 

 

4.13

 

 

 

0.88

 

5.00 and above

 

 

384,262

 

 

 

5.82

 

 

 

4.01

 

 

 

212,788

 

 

 

5.78

 

 

 

3.67

 

 

 

1,970,650

 

 

 

3.90

 

 

 

2.19

 

 

 

1,782,382

 

 

 

3.72

 

 

 

1.95

 

Schedule of Earnings (Loss) Per Share

Earnings (Loss) Per Share

 

 

For the year ended April 30,

 

 

 

2026

 

2025

 

2024

 

 

($)

 

($)

 

($)

 

Net income (loss) for the year

 

 

40,249

 

 

(4,509

)

 

13,705

 

 

 

 

 

 

 

 

 

Basic weighted average number of shares

 

 

138,950,842

 

 

126,795,491

 

 

108,639,674

 

Basic earnings (loss) per share

 

 

0.29

 

 

(0.04

)

 

0.13

 

 

 

 

 

 

 

 

 

Effect of dilutive securities

 

 

 

 

 

 

 

Warrants

 

 

 

 

 

 

6,393,228

 

Stock options

 

 

465,771

 

 

 

 

122,350

 

Diluted weighted average number of common shares

 

 

139,416,613

 

 

126,795,491

 

 

115,155,252

 

Diluted earnings (loss) per share

 

 

0.29

 

 

(0.04

)

 

0.12